Microstructural Changes in the Striatum and Their Impact on Motor and Neuropsychological Performance in Patients with Multiple Sclerosis
暂无分享,去创建一个
C. Guttmann | N. Moscufo | R. Bakshi | M. Neema | Salem Hannoun | Michele Cavallari | A. Ceccarelli | B. Glanz | J. Jackson | Christina R Matulis | Guangsong Wang | Jonathan S. Jackson | Christina R. Matulis | Mohit Neema
[1] R Bakshi,et al. The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis , 2012, American Journal of Neuroradiology.
[2] M. Dwyer,et al. Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis , 2012, American Journal of Neuroradiology.
[3] C. Guttmann,et al. Diffusion Tensor–MRI Evidence for Extra-Axonal Neuronal Degeneration in Caudate and Thalamic Nuclei of Patients with Multiple Sclerosis , 2012, American Journal of Neuroradiology.
[4] Rohit Bakshi,et al. MRI in multiple sclerosis: a review of the current literature. , 2012, Current opinion in neurology.
[5] C. Lucchinetti,et al. Meningeal and cortical grey matter pathology in multiple sclerosis , 2012, BMC Neurology.
[6] Indika S. Walimuni,et al. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS , 2012, Journal of the Neurological Sciences.
[7] Khader M Hasan,et al. Multimodal Quantitative Magnetic Resonance Imaging of Thalamic Development and Aging across the Human Lifespan: Implications to Neurodegeneration in Multiple Sclerosis , 2011, The Journal of Neuroscience.
[8] Rohit Bakshi,et al. Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[9] R Bakshi,et al. Identification and Clinical Impact of Multiple Sclerosis Cortical Lesions as Assessed by Routine 3T MR Imaging , 2011, American Journal of Neuroradiology.
[10] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[11] Richa Trivedi,et al. Quantification of age- and gender-related changes in diffusion tensor imaging indices in deep grey matter of the normal human brain , 2011, Journal of Clinical Neuroscience.
[12] A. Rovira,et al. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis , 2009, Journal of the Neurological Sciences.
[13] R Bakshi,et al. Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T , 2009, American Journal of Neuroradiology.
[14] Kunio Nakamura,et al. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients , 2009, NeuroImage.
[15] Arash Kamali,et al. Caudate nuclei volume, diffusion tensor metrics, and T2 relaxation in healthy adults and relapsing‐remitting multiple sclerosis patients: Implications for understanding gray matter degeneration , 2009, Journal of magnetic resonance imaging : JMRI.
[16] Jeremy D. Schmahmann,et al. Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems , 2008, Cortex.
[17] Yu Bai,et al. Model-based registration to correct for motion between acquisitions in diffusion MR imaging , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[18] C R G Guttmann,et al. Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.
[19] J. L. Cox,et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[20] Rohit Bakshi,et al. Gray matter involvement in multiple sclerosis , 2007, Neurology.
[21] M Riva,et al. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.
[22] R. Bakshi,et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.
[23] F. Barkhof,et al. Altered diffusion tensor in multiple sclerosis normal‐appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration , 2006, Journal of magnetic resonance imaging : JMRI.
[24] Rohit Bakshi,et al. The measurement and clinical relevance of brain atrophy in multiple sclerosis , 2006, The Lancet Neurology.
[25] Roberto Mutani,et al. Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.
[26] Derek K. Jones,et al. RESTORE: Robust estimation of tensors by outlier rejection , 2005, Magnetic resonance in medicine.
[27] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.
[28] Ralph H B Benedict,et al. Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.
[29] Massimo Filippi,et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.
[30] J. Fischer,et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. , 2001, Archives of neurology.
[31] G J Barker,et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.
[32] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[33] J K Udupa,et al. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. , 1999, AJNR. American journal of neuroradiology.
[34] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[35] H. Weiner,et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.
[36] M. Sander. Hirnrindenbefunde bei multipler Sklerose. , 1898 .
[37] Robert Zivadinov,et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.
[38] R. Bakshi,et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.
[39] J. Dawson,et al. XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.